![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DC Perry and KJ Kellar
Department of Pharmacology, George Washington University Medical Center, Washington, DC, USA.
Epibatidine, a frog skin alkaloid, is a nicotinic receptor agonist with potent analgesic activity. We used in vitro receptor autoradiographic techniques to map binding sites for [3H]epibatidine in rat brain, and those for another nicotinic agonist, [3H]cytisine. Both [3H]epibatidine and [3H]cytisine are excellent radioligands for autoradiography. [3H]Epibatidine in particular binds with very high affinity and extremely low nonspecific binding. In the present study, the distribution of binding was almost identical for both radioligands and closely resembled that of previously published autoradiographic studies with two other nicotinic ligands, [3H]acetylcholine and [3H]nicotine. Brain regions demonstrating the highest levels of [3H]epibatidine binding included the interpeduncular nucleus, medial habenular nucleus, fasciculus retroflexus, superficial gray layer of the superior colliculus and numerous thalamic nuclei, including the anteroventral, dorsal lateral geniculate and gelatinosus nuclei. Quantitative analysis revealed that [3H]epibatidine binding was greater than [3H]cytisine binding in several regions. In particular, [3H]epibatidine clearly labeled the optic nerve, optic chiasm and optic tract, whereas [3H]cytisine binding to these structures did not exceed background levels. Other regions in which [3H]epibatidine binding was greater than that of [3H]cytisine included the medial habenula, fasciculus retroflexus, olivary pretectal nucleus and superficial gray layer of the superior colliculus. The differences in labeling between these two nicotinic ligands may arise from receptor heterogeneity in brain nicotinic receptors and the ability of [3H]epibatidine to label more than one subtype of nicotine receptor.
This article has been cited by other articles:
|
|
 |
|
  H. Walsh, A. P. Govind, R. Mastro, J. C. Hoda, D. Bertrand, Y. Vallejo, and W. N. Green Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype J. Biol. Chem., March 7, 2008; 283(10): 6022 - 6032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Guo and R. A. J. Lester Ca2+ Flux and Signaling Implications by Nicotinic Acetylcholine Receptors in Rat Medial Habenula J Neurophysiol, January 1, 2007; 97(1): 83 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. McCallum, N. Parameswaran, T. Bordia, J. M. McIntosh, S. R. Grady, and M. Quik Decrease in {alpha}3*/{alpha}6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage Mol. Pharmacol., September 1, 2005; 68(3): 737 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quik, S. Vailati, T. Bordia, J. M. Kulak, H. Fan, J. M. McIntosh, F. Clementi, and C. Gotti Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA Mol. Pharmacol., January 1, 2005; 67(1): 32 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Parent and M. G. Baxter Septohippocampal Acetylcholine: Involved in but not Necessary for Learning and Memory? Learn. Mem., January 1, 2004; 11(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Nguyen, B. A. Rasmussen, and D. C. Perry Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1090 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quik, J. D. Sum, P. Whiteaker, S. E. McCallum, M. J. Marks, J. Musachio, J. M. Mcintosh, A. C. Collins, and S. R. Grady Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice Mol. Pharmacol., May 1, 2003; 63(5): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Rada, E. C. Tharakan, and P. Flood Volatile Anesthetics Reduce Agonist Affinity at Nicotinic Acetylcholine Receptors in the Brain Anesth. Analg., January 1, 2003; 96(1): 108 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Whiteaker, C. G. Peterson, W. Xu, J. M. McIntosh, R. Paylor, A. L. Beaudet, A. C. Collins, and M. J. Marks Involvement of the alpha 3 Subunit in Central Nicotinic Binding Populations J. Neurosci., April 1, 2002; 22(7): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Lee, M. Schmidt, and W. C. Hall Excitatory and Inhibitory Circuitry in the Superficial Gray Layer of the Superior Colliculus J. Neurosci., October 15, 2001; 21(20): 8145 - 8153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Whiteaker, J. M. McIntosh, S. Luo, A. C. Collins, and M. J. Marks 125I-alpha -Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain Mol. Pharmacol., May 1, 2000; 57(5): 913 - 925. [Abstract] [Full Text]
|
|
|
|
|
|
A. G. Mukhin, D. Gündisch, A. G. Horti, A. O. Koren, G. Tamagnan, A. S. Kimes, J. Chambers, D. B. Vaupel, S. L. King, M. R. Picciotto, et al. 5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors Mol. Pharmacol., March 1, 2000; 57(3): 642 - 649. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Rogers, L. C. Gahring, A. C. Collins, and M. Marks Age-Related Changes in Neuronal Nicotinic Acetylcholine Receptor Subunit alpha 4 Expression Are Modified by Long-Term Nicotine Administration J. Neurosci., July 1, 1998; 18(13): 4825 - 4832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zoli, C. Lena, M. R. Picciotto, and J.-P. Changeux Identification of Four Classes of Brain Nicotinic Receptors Using beta 2 Mutant Mice J. Neurosci., June 15, 1998; 18(12): 4461 - 4472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Marks, K. W. Smith, and A. C. Collins Differential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 377 - 386. [Abstract] [Full Text]
|
|
|
|
|
|
M. I. Dávila-García, J. L. Musachio, D. C. Perry, Y. Xiao, A. Horti, E. D. London, R. F. Dannals, and K. J. Kellar [125I]IPH, an Epibatidine Analog, Binds with High Affinity to Neuronal Nicotinic Cholinergic Receptors J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 445 - 451. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. T. Gray, S. T. Krejci, and M. D. Larson Neuromuscular Blocking Drugs Do Not Alter the Pupillary Light Reflex of Anesthetized Humans Arch Neurol, May 1, 1997; 54(5): 579 - 584. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
